Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic Disorders.
Huji Turdi,Hannguang Chao,Jon J. Hangeland,Saleem Ahmad,Wei Meng,Robert Brigance,Guohua Zhao,Wei Wang,Fang Moore,Xiang-Yang Ye,Arvind Mathur,Xiaoping Hou,James Kempson,Dauh-Rurng Wu,Yi-Xin Li,Anthony Azzara,Zhengping Ma,Ching-Hsuen Chu,Luping Chen,Mary Jane Cullen,Suzanne Rooney,Susan Harvey,Lisa Kopcho,Reshma Panemangelor,Lynn Abell,Kevin O'Malley,William J. Keim,Elizabeth Dierks,Shu Chang,Kimberly Foster,Atsu Apedo,David Harden,Marta Dabros,Qi Gao,Mary Ann Pelleymounter,Jean M. Whaley,Jeffrey A. Robl,Dong Cheng,R. Michael Lawrence,Pratik Devasthale Journal of Medicinal Chemistry（2021）
AI 理解论文
溯源树
样例
